Free Newsletter
Swiss: Lilly, Pfizer, Bayer fixed ED prices
Swiss authorities are accusing three drugmakers--Eli Lilly, Pfizer and Bayer--of forming an ED cartel. No, not the kind of cartel that's at war in Mexico, but the kind that colludes on prices. Authorities say the pharma firms are cloaking their price-fixing under a "recommended price" label; the companies have 20 days to respond. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: